CCL2 and prostate carcinoma: Previous studies have demonstrated that MCP-1 plays a pivotal role in stimulating osteoclast formation7–9,12,38,39, inducing bone loss in prostate cancer bone metastasis40–42, and periodontal bone disease43,44.